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Abstract
Legionella pneumophila, the causative agent of Legionnaires’ disease, evades phago-lysosome fusion in mammalian and
protozoan hosts to create a suitable niche for intracellular replication. To modulate vesicle trafficking pathways, L.
pneumophila translocates effector proteins into eukaryotic cells through a Type IVB macro-molecular transport system called
the Icm-Dot system. In this study, we employed a fluorescence-based translocation assay to show that 33 previously
identified Legionella eukaryotic-like genes (leg) encode substrates of the Icm-Dot secretion system. To assess which of these
proteins may contribute to the disruption of vesicle trafficking, we expressed each gene in yeast and looked for phenotypes
related to vacuolar protein sorting. We found that LegC3-GFP and LegC7/YlfA-GFP caused the mis-secretion of CPY-
Invertase, a fusion protein normally restricted to the yeast vacuole. We also found that LegC7/YlfA-GFP and its paralog
LegC2/YlfB-GFP formed large structures around the yeast vacuole while LegC3-GFP localized to the plasma membrane and
a fragmented vacuole. In mammalian cells, LegC2/YlfB-GFP and LegC7/YlfA-GFP were found within large structures that co-
localized with anti-KDEL antibodies but excluded the lysosomal marker LAMP-1, similar to what is observed in Legionella-
containing vacuoles. LegC3-GFP, in contrast, was observed as smaller structures which had no obvious co-localization with
KDEL or LAMP-1. Finally, LegC3-GFP caused the accumulation of many endosome-like structures containing undigested
material when expressed in the protozoan host Dictyostelium discoideum. Our results demonstrate that multiple Leg
proteins are Icm/Dot-dependent substrates and that LegC3, LegC7/YlfA, and LegC2/YlfB may contribute to the intracellular
trafficking of L. pneumophila by interfering with highly conserved pathways that modulate vesicle maturation.
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Introduction
When inhaled by humans, the c-proteobacterial species
Legionella pneumophila can cause a severe, acute and often fatal
form of pneumonia known as Legionnaires’ disease [1–3].
Legionella sp. remain one of the leading causes of community-
acquired pneumonia, with poor diagnosis and inadequate
treatment accounting for many of the reported fatalities [4,5]. L.
pneumophila is an environmental organism often found replicating
inside phylogenetically diverse species of amoeba and its ability to
cause disease in humans is believed to be largely accidental [6–11].
Even though the specific requirements for replication inside
protozoans and macrophages may differ [12,13], L. pneumophila’s
lifestyle in each host is quite similar.
Wild type L. pneumophila first promotes its own phagocytosis [14–
16] and then rapidly avoids phago-lysosome fusion [17–19]. The
pathogen then forms a replicative vacuole rich in early secretory
vesicles and ER-derived vesicles [20–24]. Effector proteins
specifically delivered into host cells by the Icm-Dot Type IVB
secretion system are believed to supplant or modify normal
organelle trafficking to generate and sustain the Legionella-
containing vacuole (LCV) [13,25]. Several effector proteins have
been identified which may be responsible for recruiting vesicles
from the ER to the LCV. For example, the effector protein RalF
recruits ADP-ribosylation factor -1, a critical regulator of ER and
Golgi vesicle formation, to the LCV [26]. Another regulator of ER
and Golgi vesicle traffic, Rab1, is both recruited to the LCV and
activated by the effector proteins DrrA (SidM) and LidA [27–29].
Additional signaling molecules may be targets of L. pneumophila
effectors as well, including phosphoinositides [30] and ubiquitiny-
lated proteins [31].
Recently, multiple putative effector proteins have been
identified via genetic, biochemical and bioinformatic screens
[26,32–44]. Interestingly, many L. pneumophila effector proteins
have been found to contain eukaryotic domains or have overall
similarity to eukaryotic proteins [26,33,43,45,46]. Interdomain
horizontal gene transfer has been proposed as a mechanism
through which these Legionella eukaryotic-like genes (leg) may
have been acquired [26,43,45,47]. Although the functions of some
of these effectors have been elucidated, the great majority remain
uncharacterized. With only a few exceptions, virulence phenotypes
associated with genetic deletions of individual effector proteins
have not been observed, presumably due to functional redundancy
within the pool of translocated effectors [33,34,43] and/or host
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protein may affect a single host protein or pathway, determining
the significance of individual effectors has proven challenging.
Although non-phagocytic, Saccharomyces cerevisiae shares many of
the same trafficking pathways of higher eukaryotes [49,50], and
thus offers an attractive model for the study of bacterial virulence
factors. Effectors from many bacterial pathogens, including
Chlamydia, Shigella, Pseudomonas, Yersinia, and Salmonella have been
studied in yeast [51–54]. Furthermore, yeast models have already
been used to identify and analyze L. pneumophila effectors based on
their lethal effects [36] and their ability to disrupt normal vacuolar
protein sorting (VPS) and early secretory machinery [22,38].
In this work, we report the identification of three L. pneumophila
effector proteins, LegC3, LegC2/YlfA, and LegC7/YlfB, which
are sufficient to cause VPS defects and/or altered vacuolar
morphology in yeast. Importantly, these proteins induce the
formation of and are located within similar structures when
expressed in mammalian cells. Co-localization evidence is
provided supporting the hypothesis that LegC3-GFP, LegC2/
YlfB-GFP and LegC7/YlfA-GFP are effector proteins of L.
pneumophila that can modify the normal endolysosomal pathway.
Results
Icm-Dot Dependent Translocation of Leg Proteins into
J774 Cells
In a previous report, we used a bio-informatic approach to
identify L. pneumophila eukaryotic-like genes (leg genes) based on the
occurrence of eukaryotic motifs [43]. In order to determine which
Leg proteins are substrates of the Icm-Dot system, we utilized a
novel reporter system previously used for Type-III effector
proteins [55]. In this system, TEM1 (ß-lactamase) is fused to a
putative effector protein and a strain containing this fusion protein
is used to infect host cells. Host cells are then loaded with CCF4/
AM which, when excited at 409 nm emits green fluorescence
(520 nm) due to fluorescence resonance energy transfer (FRET)
between the coumarin and fluorescein fluorophores. If the fusion
protein was translocated into host cells, it cleaves the ß-lactam ring
of CCF4/AM, releasing the two fluorophores and changing the
fluorescence emission from green to blue (447 nm) when excited at
the same wavelength. The ratio of blue to green fluorescence can
then be quantified using a spectrofluorimeter with the appropriate
excitation and emission filters.
We previously found that 8 Leg-CyaA hybrid proteins out of 20
tested are substrates of the Icm-Dot system when CyaA was fused
to the C-terminal end of the proteins [43]. In this study, we
constructed TEM1 translational fusions to all 45 leg genes in which
the Leg protein is fused to the C-terminus of TEM1 (Table 1).
Using the fluorescence-based assay, we then tested if these TEM1-
Leg hybrid proteins are translocated into J774 mouse macro-
phages. We consider a protein to be translocated if the ratio of
blue to green fluorescence in host cells is greater than 1 after
60 minutes of contact with L. pneumophila expressing the hybrid
constructs. If a ratio of less than one over background is observed
in mutants that lack essential components of the translocon (dotA or
icmT), we consider translocation to be dependent on the Icm-Dot
system. We used a TEM1-FabI hybrid protein as a negative
control, to show that the overexpression of a housekeeping protein
(Enoyl-acyl CoA Reductase) does not result in non-specific
translocation through the Icm-Dot secretion system. We also
performed immunoblots using anti-ß-lactamase antibodies on L.
pneumophila strains carrying all hybrid constructs, including those
that were found not to be translocated. With the exception of
TEM-LegA7, all hybrids are expressed at similar levels (data not
shown). We found that 33 of the 45 Leg hybrid proteins tested are
translocated in an Icm-Dot dependent manner (Figure 1).
Importantly, 23 of these Leg proteins were not previously known
to be translocated and 4 proteins (LegP, LegS2, LegC4 and
LegA3) that had given no translocation signal using the C-terminal
CyaA fusion system are in fact translocated. The 15 N-terminal
TEM1 fusions found not to be translocated in this assay were also
not translocated as C-terminal TEM1 fusions (data not shown).
These results demonstrate that a large fraction (33/45) of the
previously predicted Leg proteins are Icm-Dot substrates.
LegC3 and LegC7/YlfA cause a Vacuolar Protein Sorting
Defect in Yeast
One successful strategy used to identify proteins that are
important for intracellular trafficking has been to search for gene-
products that are required for vacuolar protein sorting (VPS) in
yeast [56–58]. Many genes required for VPS are also important
for endosomal trafficking and maturation in higher eukaryotes,
including mammals [50]. Since the Legionella-containing phago-
some avoids maturation and fusion to lysosomes, we hypothesized
that L. pneumophila may translocate effectors that specifically
interfere with conserved VPS pathways. In fact, it has been
recently shown that 3 L. pneumophila effectors (VipA, VipD, VipF)
interfere with VPS in yeast [38] while LidA interferes with steps in
the secretory pathway [22].
To find out if any Leg proteins cause a VPS defect in yeast, we
screened 29 strains that express the Leg proteins or LepA using an
invertase overlay assay (Table 1). This assay detects mis-secreted
CPY-Invertase, a protein which normally trafficks to the vacuole
[59]. The plasmid used for sub-cloning, based on the low-copy
pBM272 vector [60], creates C-terminal GFP translational fusions
to the proteins of interest with transcription regulated by a
galactose-inducible promoter. We found that the expression of
LegC3-GFP and LegC7/YlfA-GFP caused the formation of a
brown precipitate used to identify the aberrant presence of
Author Summary
Legionella pneumophila is a Gram-negative bacterial
species that causes a severe pneumonia known as
Legionnaires’ disease. Inhalation of L. pneumophila–con-
taminated aerosols results in the infection of lung
macrophages. Following infection, the bacteria use a Type
IVB secretion system to deliver multiple effector proteins
into the macrophages to create a membrane-bound
replicative compartment called the Legionella-containing
vacuole, or LCV. The LCV is defined by its recruitment of
early secretory vesicles and avoidance of the bactericidal
lysosomes. We identified several effector proteins that
contain eukaryotic domains and share significant homol-
ogy with eukaryotic organelle trafficking proteins. We
demonstrate that 33 Legionella eukaryotic-like genes (leg)
encode proteins that are translocated into host cells. When
artificially expressed in yeast, three Leg proteins (LegC2,
LegC3, and LegC7) were able to disrupt normal vesicle
trafficking and vacuole morphology. In addition, the Leg
proteins induced the formation of, and were localized
within, distinct structures when expressed in mammalian
cells. In the protozoan host Dictyostelium discoideum,
expression of LegC3 resulted in the accumulation of
membranous compartments containing partially digested
material. Thus, LegC3, LegC2, and LegC7 represent novel
effector proteins that may contribute to the intracellular
lifestyle of L. pneumophila by disrupting normal vacuolar
trafficking pathways in host cells.
Legionella Effectors Alter Organelle Trafficking
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Strains expressing GFP alone did not cause a precipitate to form,
whereas a strain expressing the Class E dominant negative protein
VPS4
E233Q [61] induced a strong VPS defect. The qualitative
assay was further verified using a quantitative assay (Figure 2B).
We conclude from these results that the L. pneumophila effector
proteins LegC3-GFP and LegC7/YlfA-GFP induce a VPS defect
when expressed in yeast cells.
Galactose-induced expression of LegC5-GFP, LegC8-GFP, and
the previously described LepB-GFP each caused a severe growth
impairment in yeast cells (Figure 3) and conclusions regarding
their effect on vacuolar sorting could not be drawn. This growth
phenotype was not dependent on the presence of the GFP tag,
since strains that expressed these Leg proteins or LepB in the
absence of additional sequence exhibited similar growth defects
(data not shown). Some Leg-GFP fusion proteins in this screen
(LegC1, LegC4, LegD2, LegK1, LegN, and LegY) did not
produce a fluorescent product as determined by epifluorescence
microscopy and others (LegK2, LegK3, LegL2, LegLC4, LegL7,
LegLC8, LegT, and LegU1) were not detectable by Western
immunoblotting with anti-GFP antibody (Figure S1). These
proteins may be poorly translated or be highly unstable when
Figure 1. Icm-Dot Dependent Translocation Leg Substrates into J774 Cells. J774 cells were infected with KS79 (WT) or KS79dotA harboring
TEM1-Leg protein fusions at an MOI of 50. Infected cells were loaded with CCF4/AM and translocation was determined by measuring the ratio of
cleaved (460 nm) to uncleaved (530 nm) CCF4/AM. Ratios of 460/530 nm emission for each TEM1-Leg protein in wild type KS79 (WT) or KS79 dotA is
shown as a heat diagram. A 460/530 nm ratio of more than 1 indicates translocation and is indicated by a horizontal dashed line. Representative
images obtained using epifluorescence microscopy on individual assay wells is shown on the right. The results shown represent the average of 2 to 3
experiments, each performed in triplicate.
doi:10.1371/journal.ppat.1000117.g001
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Plasmids Relevant Characteristics References
pMMB207C pMMB207 DmobA [33]
pXDC61 pMMB207C blaM This study
pXDC61-A1 pXDC61 legA1 This study
pXDC61-A2 pXDC61 legA2 This study
pXDC61-A3 pXDC61 legA3 This study
pXDC61-AS4 pXDC61 legAS4 This study
pXDC61-A6 pXDC61 legA6 This study
pXDC61-A7 pXDC61 legA7 This study
pXDC61-A8 pXDC61 legA8 This study
pXDC61-A9 pXDC61 legA9 This study
pXDC61-A10 pXDC61 legA10 This study
pXDC61-A11 pXDC61 legA11 This study
pXDC61-A12 pXDC61 legA12 This study
pXDC61-AU13 pXDC61 legAU13 This study
pXDC61-A14 pXDC61 legA14 This study
pXDC61-A15 pXDC61 legA15 This study
pXDC61-C1 pXDC61 legC1 This study
pXDC61-C2 pXDC61 legC2 This study
pXDC61-C3 pXDC61 legC3 This study
pXDC61-C4 pXDC61 legC4 This study
pXDC61-C5 pXDC61 legC5 This study
pXDC61-C6 pXDC61 legC6 This study
pXDC61-C7 pXDC61 legC7 This study
pXDC61-C8 pXDC61 legC8 This study
pXDC61-D1 pXDC61 legD1 This study
pXDC61-D2 pXDC61 legD2 This study
pXDC61-G1 pXDC61 legG1 This study
pXDC61-G2 pXDC61 legG2 This study
pXDC61-K1 pXDC61 legK1 This study
pXDC61-K2 pXDC61 legK2 This study
pXDC61-K3 pXDC61 legK3 This study
pXDC61-L1 pXDC61 legL1 This study
pXDC61-L2 pXDC61 legL2 This study
pXDC61-L3 pXDC61 legL3 This study
pXDC61-LC4 pXDC61 legLC4 This study
pXDC61-L5 pXDC61 legL5 This study
pXDC61-L6 pXDC61 legL6 This study
pXDC61-L7 pXDC61 legL7 This study
pXDC61-LC8 pXDC61 legLC8 This study
pXDC61-N pXDC61 legN This study
pXDC61-P pXDC61 legP This study
pXDC61-S1 pXDC61 legS1 This study
pXDC61-S2 pXDC61 legS2 This study
pXDC61-T pXDC61 legT This study
pXDC61-U1 pXDC61 legU1 This study
pXDC61-U2 pXDC61 legU2 This study
pXDC61-Y pXDC61 legY This study
pXDC61-LepA pXDC61 lepA This study
pXDC61-LepB pXDC61 lepB This study
Plasmids Relevant Characteristics References
pBM272 GAL inducible vector [60]
pKS84 pBM272 gfp This study
pKS99 pKS84 legC1 This study
pKS100 pKS84 legC2 This study
pKS101 pKS84 legC3 This study
pKS102 pKS84 legC4 This study
pKS103 pKS84 legC5 This study
pKS104 pKS84 legC6 This study
pKS105 pKS84 legC7 This study
pKS106 pKS84 legC8 This study
pKS107 pKS84 legD1 This study
pKS108 pKS84 legD2 This study
pKS109 pKS84 legG1 This study
pKS110 pKS84 legG2 This study
pKS111 pKS84 legK1 This study
pKS112 pKS84 legK2 This study
pKS113 pKS84 legK3 This study
pKS114 pKS84 legL1 This study
pKS115 pKS84 legL2 This study
pKS116 pKS84 legL3 This study
pKS117 pKS84 legLC4 This study
pKS118 pKS84 legL5 This study
pKS119 pKS84 legL6 This study
pKS120 pKS84 legL7 This study
pKS121 pKS84 legLC8 This study
pKS122 pKS84 legN This study
pKS123 pKS84 legP This study
pKS124 pKS84 legS1 This study
pKS125 pKS84 legS2 This study
pKS126 pKS84 legT This study
pKS127 pKS84 legU1 This study
pKS128 pKS84 legU2 This study
pKS129 pKS84 legY This study
pKS130 pKS84 lepA This study
pKS131 pKS84 lepB This study
pKS132 pBM272 vps4EQ This study
pKS133 pBM272 legC2 This study
pKS134 pBM272 legC3 This study
pKS135 pBM272 legC5 This study
pKS136 pBM272 legC7 This study
pKS137 pBM272 legC8 This study
pMB35 Transactivator Plasmid [75]
pMB38 Tet-off System Response Plasmid [75]




pKS138 pMB38-GFP-His7x This study
pKS140 pKS138 legC3 This study
pEGFP-N1 Mammalian expression vector Clontech
pRG6 pEGFP-N1-legC3 This study
Table 1. cont.
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defect was detected, a considerable amount of heterogeneity with
respect to protein levels was also observed. Similar to the toxic
gene products LegC5, LegC8 and LepB, it remains possible that
some of the poorly expressed Leg proteins may disrupt vacuolar
sorting or cause toxicity if different expression systems are used.
Intracellular Localization of Leg Proteins in Yeast and
their Effects on Endocytic Trafficking to the Vacuole
The styryl dye FM4-64 is commonly used to monitor the
trafficking of endocytic intermediates to the vacuole in yeast [62].
The dye first labels the plasma membrane, followed by labeling of
internalized membrane, endocytic intermediates and finally the
vacuole. Cells that have a VPS defect may present vacuolar
abnormalities that are organized into 6 distinct classes [63]. These
abnormalities can vary substantially and include defects in
acidification, vacuolar fragmentation, and accumulation of
endocytic vesicles in the pre-vacuole compartment.
Fluorescence microscopy was used to visualize the intracellular
localization of 30 Leg-GFP protein hybrids with the aid of FM4-64
to examine the vacuolar membrane. Most Leg-GFP proteins
appeared to be cytosolic or were not easily detectable and had no
apparent effect on the labeling of the vacuole by FM4-64 (data not
shown). However, we observed that three proteins, LegC2/YlfB-
GFP, LegC7/YlfA-GFP and LegC3-GFP exhibited specific
localization patterns. As shown in Figure 4A, LegC3-GFP is
found associated with the yeast plasma membrane as well as
punctate vacuolar structures within the cell. Compared to cells
expressing GFP alone, LegC3-GFP expression also caused a
partial fragmentation and tubulation of the vacuole membrane as
seen by the FM4-64 staining pattern. The punctate LegC3-GFP
containing structures also co-localized with parts of the fragmented
vacuole. In contrast, LegC2/YlfB-GFP and LegC7/YlfA-GFP
formed nodular structures on the vacuole and co-localized heavily
with the FM4-64 stain. The accumulation of FM4-64 in the pre-
vacuole is similar to what is observed in Class E VPS mutants,
indicating that these proteins block endosome maturation and
trafficking to the yeast vacuole via the multivesicular body (MVB)
pathway. Western blots on whole cell lysates using a polyclonal
rabbit anti-GFP antibody showed stable expression of all three
proteins, although LegC7/YlfA is expressed to a lower level than
LegC3 and LegC2/YlfB (Figure 4B).
Plasmids Relevant Characteristics References
pRG7 pEGFP-N1-legC3DTM This study
pRG8 pEGFP-N1-legC2 This study
pRG10 pEGFP-N1-legC7 This study
doi:10.1371/journal.ppat.1000117.t001
Table 1. cont.
Figure 2. Effector-Induced Lethality in Yeast. Yeast cells containing expression vectors for LegC5-GFP, LegC8-GFP, LepB-GFP fusion proteins or
GFP alone were spotted in 10-fold serial dilutions on SC-ura/fructose or SC-ura/galactose plates. Under conditions that induce expression of the
hybrid protein (galactose), LegC5-GFP, LegC8-GFP and LepB-GFP impair yeast growth. Under non-inducing conditions (fructose), all strains grow
comparably well.
doi:10.1371/journal.ppat.1000117.g002
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proteins depends on other components of the Vps/ESCRT
complex, we expressed these constructs in a collection of 25 VPS
mutants containing null mutations in genes that encode compo-
nents of the Vps/ESCRT complexes; (Dvps1, Dvps2, Dvps4, Dvps16,
Dvps17, Dvps18, Dvps20, Dvps22, Dvps23, Dvps24, Dvps25, Dvps27,
Dvps28, Dvps35, Dvps36, Dvps37, Dvps44, Dvps46, Dvps60, Dbro1,
Ddoa4, Dhse1, Dsec28, Dsnf7, and Dvta1). We observed that in some
cases YlfA/LegC7 and LegC3 exhibited more intense vacuolar
staining, but not mis-localization (data not shown). This result
indicates that these proteins do not require other known
scaffolding components or docking proteins of the ESCRT
complex for their association with the yeast vacuole and are likely
tethered to endosomes via putative transmembrane domains, and
not through interactions with components of the multivesicular
body pathway.
The Hydrophobic Domains of LegC2/YlfB, LegC7/YlfA
and LegC3 are required for Protein Localization and
Modification of Vacuolar Morphology
In order to determine which regions of LegC3 are required for
producing a VPS defect and localization in yeast, we analyzed a
library of LegC3 mutations. Using a transposon-based delivery
system, we obtained 60 insertions of 15 base pairs each: 33
mutations were found to contain in-frame codon insertions and 27
contained out-of-frame (nonsense) insertions (Figure 5A). We
screened the resulting yeast library for LegC3-GFP localization
and vacuolar morphology (as determined by FM4-64 staining). As
shown in Figure 5B, we found that two insertion mutants at amino
acid positions 390 (LegC3-1-GFP) and 395 (LegC3-2-GFP) altered
the protein localization and vacuolar morphology. These two
mutant proteins had transposon insertions within the hydrophobic
domain, exhibited a diffuse GFP signal, and failed to localize to the
plasma membrane. Additionally, the vacuole of cells expressing
these mutant versions of LegC3-GFP appeared to be more similar
to that of strains that express GFP alone. Western blots were
performed on lysates of yeast cells grown in fructose and galactose
to confirm that the mutant LegC3-GFP proteins were present at
the predicted sizes. As shown in Figure 5C, full length LegC3-1-
GFP and LegC3-2-GFP were expressed following galactose
induction, although the level of each protein was slightly reduced
compared to LegC3-GFP. In addition to the hydrophobic domain,
we also observed that the first 511 amino acids of the protein (out
of 558) are sufficient for causing the VPS defect, as the first
permissive truncation that still caused CPY-Invertase mis-secretion
was at this position (data not shown).
Because the amino acid insertions in LegC3-GFP that altered
the protein localization were within a hydrophobic region
predicted to be a an a-helical transmembrane domain, we decided
to test if the hydrophobic regions of LegC2/YlfB and LegC7/YlfA
were required for protein localization. As shown in Figure 6A and
6B, deleting the hydrophobic domain of LegC2/YlfB-GFP caused
the protein to become cytosolic. LegC7/YlfADTM-GFP, in
contrast, formed a single bright punctate structure distinct from
its original localization pattern on the vacuolar membrane.
Furthermore, this protein did not co-localize with the vacuole
membrane, as was the case with full-length LegC7/YlfA-GFP. As
predicted based on the transposon-mutant insertion data for
LegC3-GFP, genetic deletion of the two predicted transmembrane
domains of this protein resulted in cytosolic localization and it no
longer caused structural changes in the yeast vacuole membrane.
Western immunoblots confirmed that the deletion mutants fused
to GFP were expressed as full-length proteins of the predicted
molecular weight (Figure 6C). These results demonstrate that the
hydrophobic regions of these Leg proteins are required for their
proper localization in yeast, perhaps by anchoring them to
endocytic vesicles.
LegC3, LegC2/YlfB, and LegC7/YlfA localization in
mammalian cells
The LCV is known to recruit vesicles derived from the ER
(endoplasmic reticulum) and Golgi complex while excluding
markers of early endosomes and lysosomes [21,64]. The results
we obtained in the yeast assays are consistent with LegC3, LegC2/
YlfB, and LegC7/YlfA localizing to trafficking organelles and
possibly playing a direct role in perturbing normal vacuolar
maturation. In order to determine if similar phenotypes are
observed in higher eukaryotes, each gene was transiently expressed
in mammalian CHO cells [65] as a C-terminal GFP fusion
protein. Unfused GFP was found throughout the cytoplasm. In
contrast, LegC3-GFP formed multiple punctate structures,
although some degree of cytoplasmic expression was also evident
(Figure 7). Concordant with the results obtained in yeast cells, the
formation of punctate structures was dependent upon the
hydrophobic domain of LegC3, as deletion of this domain resulted
in a diffuse cytoplasmic distribution. To determine if LegC3-GFP
expression was associated with a specific compartment of the
endocytic pathway, immuno-fluorescent staining was performed
using antibodies against ER (a-KDEL) and lysosomal (a-LAMP-1)
markers. As shown in Figure 7, the LegC3-GFP structures had no
obvious co-localization with KDEL-containing proteins and
excluded the lysosome-associated marker LAMP-1.
In contrast to LegC3-GFP, LegC2/YlfB-GFP expression
resulted in the formation of large vacuole-like compartments.
Interestingly, these vacuole-like compartments resembled the LCV
in their strong co-localization with KDEL-containing proteins and
exclusion of LAMP-1 (Figure 8). Similarly, expression of LegC7/
YlfA-GFP localized within vacuole-like compartments, although
the relative size of these compartments was smaller than that seen
with LegC2/YlfB-GFP. Consistent with the idea that LegC2 and
LegC7 may have similar functions, the LegC7/YlfA-GFP-
containing compartments also co-localized with KDEL proteins
and did not co-localize with LAMP-1.
Figure 3. LegC3 and LegC7 Induce a Vacuolar Protein Sorting
Defect in Yeast. (A) Yeast strains expressing CPY-Inv and LegC3-GFP,
LegC7-GFP, GFP or VPS4
E233Q were streaked on SC-ura/fructose or SC-
ura/galactose and grown for four days at 30uC. As described in the
Materials and Methods, an agar solution containing chromogenic
reagents to detect invertase activity was overlaid on the plates. The
secretion of the CPY-Invertase hybrid is detected by the formation of a
brown precipitate. (B) Quantitative assay for invertase secretion. Liquid
cultures were grown to stationary phase and secreted versus total
invertase activity was measured as described in Material and Methods.
The results shown are of a representative experiment done in triplicate
+/2 standard deviations.
doi:10.1371/journal.ppat.1000117.g003
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discoideum Expressing GFP-LegC3-His7X
Due to the dramatic and novel effects of LegC3-GFP expression
on the yeast vacuole, we wanted to determine the effect of LegC3
expression in a protozoan host of L. pneumophila, D. discoideum.W e
took advantage of both epifluorescence microscopy and transmis-
sion electron microscopy (TEM) to examine cells expressing GFP-
LegC3-His7X and GFP-His7X, each under the control of a
tetracycline-regulated promoter. When examined by epifluores-
cence microscopy, cells expressing GFP-LegC3-His7X exhibited
both vesicular and lamellar staining patterns, whereas a diffuse
cytosolic staining pattern was seen with the GFP-His7X control
(Figure 9A). We next isolated a population of cells that were GFP
positive using a fluorescence activated cell sorter and processed
them for TEM using standard techniques for osmium tetroxide
staining. As shown in Figure 9B, cells expressing GFP-His7X alone
Figure 4. Steady State Localization of Leg-GFP Hybrids and Vacuole Defects. (A) Yeast strains expressing the LegC2-GFP, LegC3-GFP,
LegC7-GFP hybrid proteins and GFP alone were harvested and pulse-chased with N-(3-triethylammoniumpropyl)-4-(p-diethylaminophenylhexa-
trienyl)-pyridinium dibromide (FM4-64) for vacuole visualization. Cells were viewed using epifluorescence microscopy. The images shown are
representative of the overall population of cells expressing the Leg-GFP hybrids. (B) Whole cell lysate immunoblot using a rabbit polyclonal antibody
against GFP showing that all the GFP Leg fusion proteins are expressed under galactose induction, but not when grown in fructose. The asterisk (*) is
placed to emphasize that ten times more LegC7-GFP sample had to be loaded for visualization.
doi:10.1371/journal.ppat.1000117.g004
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undigested (labeled 1), partially digested (labeled 2) and fully
digested material (labeled 3) are visible. In contrast, cells
expressing GFP-LegC3-His7X presented an abnormally large
number of vesicles with undigested material (labeled 4). Further-
more, structures that appeared to be un-fused pro-lysosomes can
also be seen in these cells (labeled 5). This phenotype was observed
in at least 50% of the 100 cells analyzed and in less than 4% of the
cells expressing GFP-His7X alone (Figure 9C). These results
suggest that expression of GFP-LegC3-His7X may affect the
steady state formation and degradation of endosomal contents in
D. discoideum.
Discussion
Professional phagocytes have developed pathways dedicated to
killing internalized microorganisms by rapidly fusing phagosomes
with acidic and hydrolytic vesicles known as lysosomes. While the
fate of most bacteria that encounter phagocytic cells is death and
degradation, some have evolved mechanisms to avoid this
pathway. Many pathogens simply prevent phagocytosis, some
puncture the phagosome and escape into the cytosol, yet others,
such as L. pneumophila, survive by blocking phagosome maturation
altogether. However, the formation of a replication-competent
compartment is quite involved; L. pneumophila modifies its
phagosome in many different ways to transform it into a
nutrient-sufficient, non-acidic and non-hydrolytic environment.
This process is believed to require the delivery of specific effector
proteins into host cells. It is therefore important to identify and
characterize the mechanism of action of these effectors to
understand how Legionella pneumophila replicates inside host cells.
Previously, we reported the identification of 45 genes in L.
pneumophila predicted to encode proteins with distinct eukaryotic
motifs (leg genes) that may have been acquired via interdomain
horizontal gene transfer [43].
In this study, we set out to determine which of the leg genes
actually encode translocated effector proteins. We found that 25
Leg proteins are substrates of the L. pneumophila Icm-Dot
translocation system, in addition to 8 previously identified Leg
substrates. While several L. pneumophila effector proteins have been
found to interact with the early secretory machinery (such as RalF,
Figure 5. A Hydrophobic Region at the C-terminus of LegC3 is Essential for its Localization in Yeast. (A) LegC3 was mutagenized using
the GPS-LS Linker Scanning kit (New England Biolabs) to generate a library of 60 distinct mutant proteins with five amino acid insertions and 27
distinct truncation products. The positions of the 60 insertions are indicated by diamonds and the 27 truncations by triangles together with the
LegC3 structural predictions. The open diamonds and triangles represent insertion and truncation sites, respectively, that exhibited an altered LegC3-
GFP localization. (B) Epifluorescence microscopy showing specific localization patterns for LegC3-1 and LegC3-2 compared to wild-type LegC3. (C)
Whole cell lysate immunoblot using a rabbit polyclonal antibody against GFP showing that the LegC3-1 and LegC3-2 mutant proteins are stably
expressed under galactose induction.
doi:10.1371/journal.ppat.1000117.g005
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on what effector proteins may promote a block in phagosome
maturation. Here we show that three effector proteins, LegC2/
YlfB, LegC7/YlfA and LegC3, may contribute to this process.
When expressed in yeast, these predicted transmembrane proteins
seem to block the pre-vacuole compartment, preventing endo-
somes from maturing and fusing to the vacuole. This can be seen
by the accumulation of the styryl dye FM4-64 in a compartment
that contains these effector proteins and that are associated with
the vacuole. A block in endocytosis is further supported by the
observation that LegC7/YlfA and LegC3 cause mis-sorting of
CPY-Invertase, a protein that normally trafficks to the vacuole.
Interestingly, LegC2/YlfB, a paralog of LegC7/YlfA, did not
cause a detectable CPY-Invertase defect despite its vacuole-
associated localization within cells. It is possible that LegC2/YlfB
is located within membranous structures but lacks an appropriate
binding partner required for disrupting vacuolar maturation.
Moreover, CPY is only one of many cargos that traffic to the
vacuole, and certain cargos are delivered with varying genetic
requirements [66]. It will be interesting to determine the exact
Figure 6. The Predicted Transmembrane Domains of LegC2, LegC3, and LegC7 are Required for Their Localization in Yeast. (A)
Constructs of LegC2, LegC3 and LegC7 were designed to exclude the predicted transmembrane regions. The solid line drawn beneath each gene
represents the amino acid sequence included in each final construct. The truncated constructs were translationally fused to gfp and transformed into
NSY01 for expression. (B) Epifluorescence microscopy showing localization patterns. (C) Whole cell lysate immunoblot using a rabbit polyclonal
antibody against GFP showing the truncated proteins.
doi:10.1371/journal.ppat.1000117.g006
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if they perform similar roles during infection of natural host cells.
Although we did not observe a growth defect in cells that
express either LegC7/YlfA or LegC2/YlfB, these genes were
previously identified based their lethality in a similar yeast-based
assay [36]. This discrepancy may be explained by the different
vectors utilized; the previously utilized vector, pJG4-5, is a high-
copy plasmid that creates N-terminal fusions to a nuclear
localization signal and a B42 transcriptional activation domain,
which may cause effector proteins to be expressed at different
levels and localize to different organelles. The level of heterologous
gene expression can thus have important consequences on the
effects of recombinant L. pneumophila proteins in yeast-based
screens. Our finding that LegC5, LegC8 and LepB caused growth
defects in yeast may thus still prove to be interesting and useful in
finding out which cellular pathways they affect. Mutations in some
Figure 7. Localization of Leg-GFP Fusion Proteins and KDEL-containing proteins in transiently transfected CHO-FccRII cells. CHO-
FccRII cells were transfected with plasmids expressing GFP (pEGFP-N1), LegC3-GFP (pRG6), LegC3DTM (pRG7), LegC2-GFP (pRG8) or LegC7 (pRG10),
as indicated on the left of each row. Representative confocal images were acquired demonstrating the location of GFP and proteins containing KDEL
motifs as determined by immuno-fluorescent staining. Merged images are shown in the right column where yellow color designates overlap of the
green and red channels.
doi:10.1371/journal.ppat.1000117.g007
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yeast (personal communications, Scott Emr). It is intriguing that
LepB, a protein that may have a role in the release of the bacteria
from protozoan (but not mammalian) hosts, strongly inhibits
growth in yeast. LepB has recently been shown to also act as a
GTPase-activating protein functioning to remove Rab proteins
from the LCV [27]. The lethal effect of LepB expression may open
the way for the study of the effects of this effector protein on
exocytosis pathways in yeast.
One caveat to yeast-based screens is that overexpressed
proteins, particularly those carrying predicted transmembrane or
hydrophobic domains, may produce artificial results. However, a
recent study has shown that the overproduction of integral-
membrane proteins in yeast seems to cause effects that are mainly
protein-specific [67]. In addition, we only observed phenotypes for
a small number of effector proteins, even though many contained
hydrophobic domains. One notable conclusion from our studies is
that only effector proteins that contain coiled-coil domains
Figure 8. Localization of Leg-GFP Fusion Proteins and LAMP-1 in transiently transfected CHO-FccRII cells. CHO-FccRII cells were
transfected as in Figure 7. Representative confocal images demonstrating the location of GFP and LAMP-1 staining are shown. When present, arrows
indicate the location of GFP-positive structures to distinguish these from proximal LAMP-1 lysosomes. Merged images are shown in the right column.
The lack of yellow color in merged verifies a lack of colocalization between GFP-positive structures and lysosomes.
doi:10.1371/journal.ppat.1000117.g008
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binding domain is often found in eukaryotic trafficking proteins
and in many VPS proteins in yeast. This raises the possibility that
effector proteins with other domains either affect pathways we did
not test, or do not function in yeast.
TEM analysis of D. discoideum cells expressing GFP-LegC3-
His7X revealed fine structure modifications that are difficult to
observe using other types of microscopy. Here we show that
expressing this protein in D. discoideum causes the accumulation of
many vesicles with undigested matter. This is of direct relevance to
L. pneumophila’s lifestyle, since this organism is known to alter
membrane trafficking in such a way that endocytic maturation is
locally halted. One complicating factor, nonetheless, is the finding
that a certain portion of the overexpressed LegC3 seems to remain
localized to lamellar structures that may be ER. Others have
demonstrated that the overexpression of certain proteins in D.
discoideum may lead to the accumulation of aggregates in the ER
cisternae [68]. However, the TEM pictures of these aggregated
ER cisternae are quite distinct from the TEM images of cells
expressing GFP-LegC3-His7X. Furthermore, the accumulation of
proteins in the ER does not interfere with endocytic vesicles in the
previous studies. The dramatic effects that LegC3 causes in both
Figure 9. Expression of GFP-LegC3-His7X and GFP-His7X in D. discoideum. (A) D. discoideum cells containing GFP-His7x,o rGFP-LegC3-His7x
under the control of a Tc-repressible promoter were grown with the presence of 10 mg/mL of Tc for 3 days at 25uC. The cells were washed in SorC
buffer and incubated for an additional 8–10 hours in media without tetracycline. Expression of the fusion proteins was visualized under
epifluorescence microscopy. (B) D. discoideum cells expressing hybrid fusion proteins were sorted for GFP+ cells after 10 hours of induction. The
samples were then fixed and processed for electron microscopy using osmium tetroxide staining. Cells expressing GFP-His7X contain a mixture of
vesicles with (1) undigested material, (2) partly digested material and (3) completely digested material. At least half of the cells expressing GFP-LegC3-
His7X contain (4) an abnormally high number of vesicles with partly digested contents. What appears to be unfused pro-lysosomes (5) are segregated
to a separate portion of the cell. (C) At least 100 cells of each sample were analyzed for abnormal fine structures. The percentage of GFP-LegC3-His7X
expressing cells containing abnormal vesicle accumulation versus GFP-His7X expressing cells. 95% confidence intervals are indicated above.
doi:10.1371/journal.ppat.1000117.g009
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that this effector plays an important role in L. pneumophila’s ability
to arrest phago-lysosome fusion.
Following ectopic expression of LegC3, LegC2/YlfB, and
LegC7/YlfA as GFP fusion proteins in mammalian CHO cells,
specific intracellular localization patterns were observed. LegC3-
GFP was concentrated within multiple distinct, punctate structures
and this localization was dependent on the presence of the
hydrophobic, putative transmembrane domain. The LegC3-
containing structures did not appear to co-localize with either
the ER or early secretory vesicles (based on a-KDEL staining) or
late endosomes/lysosomes. As such, we cannot currently deter-
mine whether LegC3 is specifically targeted to a specific organelle
or pathway in mammalian cells. It is interesting to note, however,
that the punctate localization of LegC3 within mammalian cells is
similar to that observed in the yeast screen, suggesting that LegC3
association with membranes plays an important role in its function
in each cell type.
In contrast to what was observed with LegC3-GFP, ectopic
expression of LegC2/YlfB-GFP and LegC7/YlfA-GFP in mam-
malian cells induced the formation of and appeared within large
vesicle-like structures. In each case, these structures co-localized
with KDEL-containing proteins and excluded the lysosomal
marker LAMP-1, concurring with previous results reported for
LegC7/YlfA [36]. Notably, these vacuole-like structures are
similar to the LCV in their association with ER-resident proteins
and exclusion of LAMP-1, suggesting that each protein is sufficient
to remodel vacuolar trafficking, perhaps to benefit the intracellular
survival of L. pneumophila.
Drawing conclusions about individual effector proteins based on
their ectopic expression in the absence of the infectious organism
may be regarded with skepticism. However, we believe this is a
useful strategy to assist in determining the function and
significance of effector proteins in the infectious process. Single
or even multiple deletions of putative effector proteins rarely have
any observed effect on the ability of L. pneumophila to infect and
replicate in host cells. In fact, although our results might suggest a
significant role for LegC2/YlfB and LegC7/YlfA in modulating
the LCV, strains deleted for both genes replicated in protozoan
and mammalian host cells with similar kinetics to wild type [36].
The lack of an intracellular growth phenotype in single or double
knockout strains is presumed to be due to a redundancy within the
pool of translocated effectors, where multiple proteins may target
the same pathway(s). The extensive set of homologous effectors
present in L. pneumophila may be explained by their origin. If
effectors were originally acquired via horizontal gene transfer and
then duplicated over time, this set of ‘‘foreign’’ genes could serve as
a pool for the selection of effectors whose functions are fine-tuned
for specific interactions and/or specific host species. What may
first look like ‘‘redundancy’’ may in fact be a source of untapped
resources that allows this pathogen to evolve and survive in several
distinct niches. The genome sequence of L. pneumophila may thus
represent just a snap-shot of effector genes during the process of
evolution.
At present, it is difficult to determine which host pathways are
appropriated by specific effector proteins. Nevertheless, the
importance of the Icm-Dot TFSS for the virulence of L. pneumophila
strongly supports the belief that effector proteins translocated into
host cells are required to prevent normal bactericidal responses.
Our results demonstrate that LegC3, LegC2/YlfB, and LegC7/
YlfA can affect normal vacuolar trafficking in yeast, protozoan,
and mammalian cells. The data presented here suggest that
endosomal trafficking and particularly the Vps/ESCRT pathway
may play a role in the construction or maintenance of the
Legionella-containing vacuole. Additional work should provide
information about the involvement of this or other conserved host
cell pathways in the intracellular lifestyle of L. pneumophila.
Materials and Methods
Bacterial and Yeast Strains
The bacterial and yeast strains used in this study are listed in
Table 2. With the exception of KS79, bacterial strains, media and
antibiotics are described elsewhere [43]. KS79 is an isogenic
DcomR derivative of JR32. This strain was generated by the
isolation of a Tn903dIIlacZ insertion in the comR gene followed by
the removal of the entire ORF, including the transposon, to
generate an unmarked comR mutant. Generation of the yeast strain
NSY01 is described elsewhere [38].
Construction of Plasmids
Descriptions of all cloning strategies are described below, and a
complete list of plasmids used in this study is provided in Table 1.
The blaM gene encoding the mature form of TEM-1 beta-
lactamase (residues 24–286) was amplified by PCR from pUC18
with forward and reverse primers introducing a ribosome-binding
site and a KpnI-SmaI-BamHI-XbaI polylinker at the 39 end. The
PCR product was cloned into EcoRI/HindIII digested
pMMB207C [33] to generate plasmid pXDC61. The leg genes
were PCR-amplified and cloned in frame with the beta-lactamase
at the KpnI-XbaI sites. The leg genes that contain one of these
restriction sites were cloned into 76XbaI (legA10-S2-T), KpnI
(legC7-C8-U1) or BamHI site (LegK1). The resulting plasmids
were then introduced by natural transformation into KS79 (JR32
DcomR), KS79 dotA::Tn903dIIlacZ or KS79 icmT::Tn903dIIlacZ.
The low-copy, galactose inducible plasmid pBM272 is described
elsewhere [60]. The gfp S65T variant was amplified by PCR with
primers containing the restrictions sites HindIII/SalI. The PCR
product was double-digested with these enzymes and cloned into
the HindIII/SalI sites of pBM272 to generate pKS84. 30 leg genes
and LepA and LepB were amplified by PCR with primers
containing the appropriate restriction sites and inserted either into
the BamHI site or HindIII site of pKS84 to generate leg-GFP
fusions. To create un-fused version of these proteins, legC2, legC3,
legC5, legC7, lepA and lepB were also cloned into pBM272 using
identical restriction sites. These plasmids were introduced into
NSY01 by the Lithium Acetate transformation method [69].
pKS138 was constructed by inserting a DNA fragment
encoding a His7x tag into the Sph1 and Mlu1 sites of pMB38-
GFP (a generous gift from Barbara Weissenmayer at the Berlin
University). legC3 was amplified by PCR with primers containing
BamHI restriction sites subsequently digested with the appropriate
enzymes. The product was inserted into the BamHI site of
pKS138. Plasmids pKS138 and pKS140 were transformed into D.
discoideum AX2 MB35 by electroporation.
Table 2. Strains Used in This Study
Strains Relevant Genotypes Reference
JR32 Philadelphia-1, Sm
R, r-, m+ [73]
KS79 JR32 DcomR This study
NSY01 BHY10 diploid [38]
D. discoideum AX2 Standard Axenic Strain [74]
doi:10.1371/journal.ppat.1000117.t002
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and legC7 were amplified by PCR using oligonucleotides that
introduced an NheI site and a Kozak consensus sequence
(gccgccaccATGgtg) immediately before each gene at the 59 end
and a KpnI site at the 39. PCR products were sub-cloned into
pEGFP-N1 (Clontech) at the NheI and KpnI sites using
unidirectional cloning to generate translational Leg-GFP fusion
proteins under the transcriptional control of the CMV I/E
promoter.
TEM Translocation assays and Immunoblots
J774 cells grown in RPMI containing 10% fetal calf serum
(FCS) were seeded in black clear-bottom 96-well plate at 1x10
6
cells/well 24 hours prior to infection. L. pneumophila strains
carrying the various blaM fusions were grown on CYE plates
containing choramphenicol and single colonies were then streaked
on CYE plates containing chloramphenicol and 0.5 mM Isopropyl
b-D-1-thiogalactopyranoside (IPTG) and grown for 24 hours to
induce expression of the hydrid proteins. 10 mL of bacteria re-
suspended in RPMI at 5610
8 cells/mL were used to infect J774
cells (MOI=50). After centrifugation (600g, 10 minutes) to initiate
bacterial-cell contact the plate was shifted to 37uC and incubated
for one hour with CO2 exchange. Cell monolayers were loaded
with the fluorescent substrates by adding 20 ml of 6x CCF4/AM
solution (LiveBLAzer-FRET B/G Loading Kit, Invitrogen)
containing 15 mM Probenecid (Sigma). The cells were incubated
for an additional 2 hours at room temperature. Fluorescence was
quantified on a Victor microplate reader (Perkin-Elmer) with
excitation at 405 nm (10-nm band-pass), and emission was
detected via 460-nm (40-nm band-pass, blue fluorescence) and
530-nm (30-nm band-pass, green fluorescence) filters. Transloca-
tion was expressed as the emission ratio at 460/530 nm to
normalize the ß-lactamase activity to cell loading and the number
of cells present in each well. The presented data are mean values
of the results from triplicate wells from two to three experiments.
The cells were also visualized by fluorescence microscopy using an
inverted microscope equipped with the Beta-lactamase ratiometric
filter set (Chroma).
Yeast Microscopy and FM4-64 Staining
S. cerevisiae cells expressing effector proteins were grown
overnight in 3 mL cultures at 30uC in SC-Ura/fructose. The
cultures were then back-diluted to A600 of 0.4–0.6 in 3 mL of SC-
Ura/galactose and grown to A600 of 0.8–1.2. For vacuolar
staining, the induced cultures were centrifuged and re-suspended
in YP medium containing 2% galactose. N-(3-triethylammonium-
propyl)-4-(p-diethylaminophenylhexatrienyl)-pyridinium dibro-
mide, FM4-64 (Molecular Probes), was added to a final
concentration of 40 mM. After 15 minutes of incubation at
30uC, the cells were washed twice and re-suspended in 3 mL of
fresh YP medium containing 2% galactose. We allowed cells to
incubate for an additional 45–60 minutes before visualization. We
visualized cells under a Nikon Eclipse TE200 at 100x using an oil
immersion phase-contrast objective. For fluorescence microscopy,
we utilized filter sets for fluorescein isothiocyanate and Texas red.
For Z-stack image acquisition, we used a Hamamatsu digital
camera with a computer-controlled Z-axis drive. We acquired
approximately 20 Z-sections every 0.3–0.4 mm (spanning 6–8 mm)
and performed volume deconvolution using Improvision’s Open
Lab software.
Invertase Assays
The quantitative and qualitative invertase assays were based on
a previous published methodology [59]. For the qualitative assay,
cells streaked on SC-Ura/galactose or SC-Ura/fructose plates
were incubated for 4 days at 30uC. The plates were overlaid with
0.75% agar solution containing 125 mM sucrose, 100 mM sodium
acetate buffer (pH 5.5), 0.5 mM N-ethylmaleimide (NEM), 10 mg/
mL horseradish peroxidase, 8 units/mL glucose oxidase, and
2m MO-dianisidine. After 5–15 minutes, pictures were taken with
a Sony Cybershot camera. Image contrast was adjusted using the
open source software GIMP. For the quantitative assays, cells were
grown in liquid SC-Ura/galactose to stationary phase and split
into two samples for measurement of total invertase activity and
exogenous invertase activity. The assay was scaled down and
performed in 96-well plates. To measure total invertase activity,
one of the samples was first lysed by the addition of Triton X to a
final concentration of 2% followed by 4 cycles of freeze-thaw.
20 mL of each sample was then mixed with 20 mL of a 0.1 M
Sodium Acetate (pH 4.9) solution and 5 mL of a 0.5 M sucrose
solution followed by incubation at 30uC for 30 minutes. To
inactivate the invertase enzyme, 30 mL of 0.2 M K2HPO4
(pH 10.0) was added followed by heating to 95uC for 10 minutes.
The samples were then allowed to cool down to room temperature
and mixed with 150 mL of the glucostat reagent [59]. The
reactions were stopped by the addition of 200 mL of 6M HCl. The
A540nm of all samples was measured using a microplate reader
(Molecular Device). The units of invertase enzyme were calculated
using a standard glucose curve and the following definition: one
unit of invertase is the amount of enzyme that hydrolyzes sucrose
to produce 1 mM of glucose per minute at 30uC.
Generation of LegC3 Insertion and Truncation Library
The LegC3 mutant library was generated using the GPS-LS
Linker Scanning kit (New England Biolabs). We followed the
manufacturer’s protocol to generate a collection of 92 transposon-
generated mutations in the LegC3 gene. On average, 2/3 of the
mutants generated have 15 bp insertions in the gene of interest
while 1/3 of them create truncated products. We sequenced the
whole library (Genewiz, inc.) to determine the exact nature and
location of each mutation. The 92 plasmids were then transformed
into NSY01 for further analysis. The LegC3-1-GFP mutant
protein has an insertion at amino acid position 390 of VFKQS and
LegC3-2 an insertion at amino acid position 395 of CLNTF.
Yeast Immunoblots
Yeast strains were grown on SC Ura/Fructose plates for two
days at 30uC. Several colonies were picked and spread on SC
Ura/Galactose plates and incubated for three days at 30uC. Yeast
cells were scraped with 10 mL of 50 mM Tris-HCl pH 7.5 and
then centrifuged at 10,000 rpm for 5 minutes. The cells were then
re-suspended in 2 mL of 50 mM Tris-HCl pH 7.5, divided into
0.5 mL aliquots and frozen at 280uC. The frozen pellet was then
re-suspended in an additional 0.5 mL of 50 mM Tris-HCl pH 7.5
and the absorbance at 600 nm measured. An amount equivalent
to OD 5 in a total volume of 300 mL of Tris-SB was boiled for
5 minutes. The sample LegC7-GFP was concentrated ten times
relative to this measurement. 15 mL was loaded onto 4–15%
polyacrylamide gradient gels. Following electrophoeresis, the
proteins were transferred to a nitrocellulose membrane and
processed for immunoblots using an affinity-purified rabbit
polyclonal antibody to GFP at a 1:2,000 dilution [70].
D. discoideum Epifluorescence Microscopy
D. discoideum cells containing pKS138 and pKS140 were grown
for three days with slow shaking in a 22uC water bath. The cells
were then washed 3 times with an equal volume of SorC buffer.
The cells were then re-suspended in HL5 medium and allowed to
Legionella Effectors Alter Organelle Trafficking
PLoS Pathogens | www.plospathogens.org 14 August 2008 | Volume 4 | Issue 8 | e1000117grow for an additional 6–10 hours at 22uC [71]. We visualized
cells under a Nikon Eclipse TE200 at 1006using an oil immersion
phase-contrast objective. For fluorescence microscopy, we utilized
filter sets for fluorescein isothiocyanate.
Dictyostelium Electron Microscopy
D. discoideum cells containing pKS138 and pKS140, grown for
three days with slow shaking in a 22uC water bath, were washed 3
times with an equal volume of SorC buffer, resuspended in HL5
medium and grown for an additional 10 hours at 22uC. Cells were
spun down at low speed, re-suspended in SorC buffer, prepared
for sorting at the Columbia University Cell Sorting facility, and
one million GFP
+ cells of each strain were sorted. The cells were
plunged into ice and prepared for TEM according to the O R
Anderson method [72]. An equal volume of suspended cells was
added to a 6% TEM grade glutaraldehyde [Ladd 20215] solution
containing HL5 and SorC buffer, gently placed on ice for
30 minutes, resedimented by gentle centrifugation, and the pellet
was post-fixed with 1 mL of 2% osmium tetroxide solution [Ladd
55090] in cacodylate buffer. The post-fixed cells were sedimented
by gentle centrifugation. The pellet was gently resuspended in
0.8% ionagar sol at 42uC by flicking the tube, rapidly pelleted in
the agar sol by centrifugation and the enrobed pellet solidified by
placing the tube in an ice bath. The enrobed pellet was removed
from the tube with a spatula, washed in water, and dissected into 1
mm
3 segments. The segments were washed in water, dehydrated
in a graded aqueous acetone series, infiltrated with and embedded
in low viscosity epon, placed in BEEM capsules containing the
epon, and polymerized for 24 hours at 72uC. Ultrathin sections,
obtained with a Porter-Blum MT-2 Ultramicrotome fitted with a
diamond knife, were collected on uncoated copper grids, post-
stained with Reynold’s lead citrate, and observed at 60 kV with a
Philips 201 TEM.
Mammalian immuno-staining and confocal microscopy
CHO-FccRII cells [65] were maintained in a-MEM media
containing 10% FBS. Cells were seeded at 2610
4 cells/well on
12 mm coverslips and incubated overnight. The following day,
cells were transfected with plasmid DNA using Fugene HD
(Roche) according to the manufacturers instructions. 16 hours
later, cells were fixed with 3.7% PBS-buffered formalin for
20 minutes, washed with PBS, and blocked/permeabilized with
2% BSA in PBS containing 0.1% saponin. All subsequent buffers,
including wash buffers, contained 0.1% saponin. Cells were
incubated with blocking buffer containing primary antibodies
against KDEL (1:200) (Santa Cruz Biotechnology) or UH1, a
monoclonal antibody against hamster Lgp-A/LAMP-1 (1:200)
(DSHB, University of Iowa) for 1 hour, washed, and incubated
with goat anti-mouse Alexa Fluor 564 (1:500) (Invitrogen) for
30 minutes. After washing, coverslips were fixed to glass slides
using Vectashield HardSet mounting media (Vector Labs) for
confocal microscopy. Confocal images were acquired with a Zeiss
LSM510 Meta laser scanning microscope. Captured images were
processed and merged using the open-source NIH software,
ImageJ (http://rsb.info.nih.gov/ij/index.html).
Supporting Information
Figure S1 Detection of Leg-GFP proteins in yeast by immuno-
blot analysis. (A) Table A shows the plasmids that did not result in
detectable fluorescence in yeast after galactose induction as
determined by fluorescent microscopy. (B) Table B shows plasmids
that did not produce a detectable band after immunoblotting but
did show low levels or diffuse GFP localization by fluorescent
microscopy. (C, D, E, F) Immunoblots on yeast lysates following
galactose induction. The expression construct and predicted
molecular weight are shown above each respective lane.
Immunoblots were performed as described in Materials and
Methods.
Found at: doi:10.1371/journal.ppat.1000117.s001 (2.72 MB TIF)
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